Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses

被引:0
|
作者
Cardo, E. [1 ,2 ]
Coghill, D. [3 ]
Nagy, P. [4 ]
Adeyi, B. [5 ]
Anderson, C. [6 ]
Caballero, B. [7 ]
Higgins, N. [8 ]
Hodgkins, P. [9 ]
Civil, R. [10 ]
Dittmann, R. W. [11 ]
机构
[1] Univ Balearic Isl, Son Llatzer Hosp, Palma De Mallorca, Spain
[2] Res Inst Hlth Sci, Palma De Mallorca, Spain
[3] Univ Dundee, Div Neurosci, Dundee, Scotland
[4] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[5] Shire Dev LLC, Global Biostat, Wayne, NJ USA
[6] Shire Dev LLC, Global Clin Programs, Wayne, NJ USA
[7] Shire AG, Clin Dev & Med Affairs, Eysins, Switzerland
[8] Shire Dev LLC, Clin Programs, Wayne, NJ USA
[9] Shire Dev LLC, Global Hlth Econ & Outcomes Res, Wayne, NJ USA
[10] Shire Dev LLC, Clin Dev & Med Affairs, Wayne, NJ USA
[11] Heidelberg Univ, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
关键词
D O I
10.1016/S0924-977X(13)70960-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.7.d.008
引用
收藏
页码:S603 / S604
页数:2
相关论文
共 50 条
  • [41] Efficacy of atomoxetine treatment in children with ADHD and epilepsy
    Barragán, E
    Hernandéz, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S115 - S115
  • [42] Efficacy of atomoxetine treatment in children with ADHD and epilepsy
    Hernández, AJC
    Barragán, PEJ
    EPILEPSIA, 2005, 46 : 241 - 241
  • [43] Does Prior Exposure to Stimulants in Children with ADHD Impact Cardiovascular Parameters From Lisdexamfetamine Dimesylate?
    Wigal, Sharon B.
    Jun, Angela
    Wong, Amanda A.
    Stehli, Annamarie
    Steinberg-Epstein, Robin
    Lerner, Marc A.
    POSTGRADUATE MEDICINE, 2010, 122 (05) : 27 - 34
  • [44] Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
    Childress, Ann
    Cutler, Andrew
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    Findling, Robert
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 533 - 533
  • [45] ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years
    Lopez, Frank A.
    Childress, Ann
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Lasser, Robert A.
    Shepski, John
    Arnold, Valerie
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 52 - 61
  • [46] Plasma atomoxetine concentration and response to ADHD in children and adolescents
    Michelson, D
    Gao, HT
    Allen, AJ
    Witcher, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2002, 12 (04) : 291 - 291
  • [47] LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
    Coghill, D.
    Hernandez Otero, I.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Geibel, B.
    Naser, N.
    Yan, B.
    Banaschewski, T.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 162 - 162
  • [48] Do children and adolescents with ADHD respond differently to atomoxetine?
    Wilens, TE
    Kratochvil, C
    Newcorn, JH
    Gao, HT
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (02): : 149 - 157
  • [49] Safety profile of atomoxetine in the treatment of children and adolescents with ADHD
    Wernicke, JF
    Kratochvil, CJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 50 - 55
  • [50] Head-to-head study confirms atypical antipsychotic efficacy equivalence
    不详
    FORMULARY, 2005, 40 (11) : 407 - 407